Can Mounjaro Cause Diarrhoea? What the Evidence Says

The first few weeks: what most people's experience looks like

Picture this: it is week two of your first Mounjaro pen and you have noticed your stomach is moving faster than usual. Loose stools or diarrhoea in the early weeks is one of the patterns our prescribers hear about most often from people starting tirzepatide. The mechanism is straightforward: Mounjaro slows gastric emptying and changes how quickly food moves through the gut. While your digestive system recalibrates, that shift can mean urgency, looser stools, or episodes of diarrhoea, sometimes on the day or two after your weekly injection, sometimes more spread out.

In clinical trials of tirzepatide, diarrhoea was reported by a meaningful proportion of participants, particularly at higher doses and during dose increases. The NHS tirzepatide page lists it explicitly as a common side effect. For most people, the intensity settles within a couple of weeks at each dose level. If you are wondering whether the pattern you're experiencing is typical, a quick practical check is useful: keep a loose note on your phone for three or four days of when episodes happen relative to your injection day, that pattern alone often tells you and your prescriber a great deal.

Low-fat, lower-fibre foods during flare days, smaller meals, and steady fluid intake are the straightforward steps most people find helpful. You can read more about the full range of gastrointestinal effects on our Mounjaro side effects page.

Why Mounjaro is more likely to cause diarrhoea at some points than others

Diarrhoea does not tend to be constant throughout treatment. It clusters around two windows: the first few weeks after starting, and the days following a dose increase. This is not a sign something has gone wrong; it reflects the gut adapting to a higher level of GIP and GLP-1 receptor activity. The stomach empties more slowly, bile acid release patterns shift, and gut motility changes, all of which can tip the balance towards loose stools for a period.

The starting dose of 2.5mg exists partly to give the digestive system time to adjust before stepping up. Even so, some people notice gut symptoms at every dose level; others experience them only at the beginning and then not again. Individual variation here is wide, and the underlying reasons Mounjaro affects the gut are worth understanding if you want the full picture.

One thing worth knowing: tirzepatide is not unique in this respect. Other GLP-1 and dual-agonist medicines share a similar gastrointestinal profile. Our page on tirzepatide and diarrhoea covers the pharmacology in more detail if you want it.

When diarrhoea on Mounjaro needs medical attention

Mild, brief episodes are expected and generally not a reason to stop treatment. But certain signs mean you should contact a clinician the same day, or go to A&E if they are severe.

Seek help promptly if: diarrhoea is severe or has not settled after more than a few days; you are unable to keep fluids down alongside the diarrhoea; you notice signs of dehydration (pronounced thirst, dark urine, dizziness when you stand, significantly reduced urine output); or you develop stomach pain that is severe and persistent, especially if it spreads to your back. That last symptom, with or without vomiting, is the warning sign associated with pancreatitis, a serious but infrequent reaction that the MHRA highlighted in a formal Drug Safety Update in January 2026. Pancreatitis is rare, but it should not be waited out at home.

If you are experiencing side effects and are a current patient, our team is available seven days a week, the contact page has everything you need. If you want to understand how fatigue or other symptoms fit alongside gut effects, this page on tiredness with Mounjaro may help. Suspected side effects from any medicine can be reported via the MHRA's Yellow Card scheme, which is free to use and open to patients directly.

Starting Mounjaro: how a prescriber looks at your gut health first

Before tirzepatide is prescribed, a clinician reviews your full medical history, including any existing gut conditions, history of pancreatitis, or medications that might interact. This is not box-ticking; it is the step that makes the difference between a treatment plan that manages side effects sensibly and one that misses a reason to pause.

At nume, a GPhC-registered prescriber reads every consultation personally. If diarrhoea or other GI symptoms come up during treatment, they are part of the clinical conversation at every repeat review, not a question you have to raise unprompted. Treatment through a regulated service means those conversations happen. If you are considering whether Mounjaro is right for you, our free consultation is where that assessment starts. General information about how tirzepatide works and what to expect is on our Mounjaro overview. And if you want to understand private access more broadly, the how to get Mounjaro online page covers the regulated route clearly.